ALKS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Alkermes Plc (ALKS) does not present a compelling buy opportunity for a beginner, long-term investor at this time. While the technical indicators show some bullish trends, the lack of strong positive catalysts, weak financial performance, and neutral sentiment from hedge funds and insiders suggest a cautious approach. The stock is better suited for monitoring rather than immediate investment.
The technical indicators show a bullish trend with SMA_5 > SMA_20 > SMA_200. MACD is positive but contracting, and RSI is neutral at 55.584. The stock is trading near its pivot level of 33.982, with key resistance at 35.145 and support at 32.818.
Bullish moving averages and a slight positive regular market price change of 1.64%.
Weak financial performance in Q4 2025 with significant YoY declines in revenue (-10.57%), net income (-66.32%), and EPS (-67.05%). No recent news or congress trading data. Neutral sentiment from hedge funds and insiders.
In Q4 2025, revenue dropped to $384.55M (-10.57% YoY), net income fell to $49.34M (-66.32% YoY), and EPS declined to $0.29 (-67.05% YoY). However, gross margin improved slightly to 87.98% (+2.84% YoY).
Analysts have mixed views. Recent updates include a price target increase to $36 from $34 by BofA with a Neutral rating, and RBC Capital lowering the price target to $44 from $45 while maintaining an Outperform rating. Analysts highlight potential growth in the sleep franchise but also note seasonal headwinds and macro challenges.
